联系我们  |  网站地图  |  English   |  移动版  |  中国科学院 |ARP
站内搜索:
首页 简介 管理部门 科研部门 支撑部门 研究队伍 科研成果 成果转化 研究生教育 党建与创新文化 科普 信息公开 办公内网
科技信息
Low-cost wearables manuf...
Researchers develop 3-D-...
硫化钴能用来制作超级电容
青岛能源所在石墨炔能源存...
二维非铅钙钛矿动力学机理...
Scientists fine-tune sys...
Amorphous diamond synthe...
化学耦合的硫化镍和碳空心...
全无机钙钛矿光电探测器动...
科研人员提出纳米催化医学...
Newly-discovered semicon...
Molecular nanoparticles ...
碳纳米点固态高效发光新方法
基于甲胺气体的钙钛矿薄膜...
新型镁电池可使储能技术更...
现在位置:首页>新闻动态>科技信息
A new method for the 3-D printing of living tissues
2017-08-16 09:39:07 | 编辑: | 【 【打印】【关闭】

 

Image of the 3-D droplet bioprinter, developed by the Bayley Research Group at Oxford, producing mm-sized tissues Credit: Sam Olof/ Alexander Graham

  Scientists at the University of Oxford have developed a new method to 3D-print laboratory- grown cells to form living structures.

  The approach could revolutionise regenerative medicine, enabling the production of complex tissues and cartilage that would potentially support, repair or augment diseased and damaged areas of the body.

  In research published in the journal Scientific Reports, an interdisciplinary team from the Department of Chemistry and the Department of Physiology, Anatomy and Genetics at Oxford and the Centre for Molecular Medicine at Bristol, demonstrated how a range of human and animal cells can be printed into high-resolution tissue constructs.

  Interest in 3D printing living tissues has grown in recent years, but, developing an effective way to use the technology has been difficult, particularly since accurately controlling the position of cells in 3D is hard to do. They often move within printed structures and the soft scaffolding printed to support the cells can collapse on itself. As a result, it remains a challenge to print high-resolution living tissues.

  But, led by Professor Hagan Bayley, Professor of Chemical Biology in Oxford's Department of Chemistry, the team devised a way to produce tissues in self-contained cells that support the structures to keep their shape.

 

A confocal micrograph of an artificial tissue containing 2 populations human embryonic kidney cells (HEK-293T) printed in the form of an arborized structure within a cube Credit: Sam Olof / Alexander Graham

  The cells were contained within protective nanolitre droplets wrapped in a lipid coating that could be assembled, layer-by-layer, into living structures. Producing printed tissues in this way improves the survival rate of the individual cells, and allowed the team to improve on current techniques by building each tissue one drop at a time to a more favourable resolution.

  To be useful, artificial tissues need to be able to mimic the behaviours and functions of the human body. The method enables the fabrication of patterned cellular constructs, which, once fully grown, mimic or potentially enhance natural tissues.

  Dr Alexander Graham, lead author and 3D Bioprinting Scientist at OxSyBio (Oxford Synthetic Biology), said: "We were aiming to fabricate three-dimensional living tissues that could display the basic behaviours and physiology found in natural organisms. To date, there are limited examples of printed tissues, which have the complex cellular architecture of native tissues. Hence, we focused on designing a high-resolution cell printing platform, from relatively inexpensive components, that could be used to reproducibly produce artificial tissues with appropriate complexity from a range of cells including stem cells".

  The researchers hope that, with further development, the materials could have a wide impact on healthcare worldwide. Potential applications include shaping reproducible human tissue models that could take away the need for clinical animal testing.

  The team completed their research last year, and have since taken steps towards commercialising the technique and making it more widely available. In January 2016, OxSyBio officially spun-out from the Bayley Lab. The company aims to commercialise the technique for industrial and biomedical purposes.

 

An image of the 3-D droplet bioprinter, developed by the Bayley Research Group at Oxford, producing mm-sized tissues Credit: Sam Olof/ Alexander Graham

  Over the coming months they will work to develop new complementary printing techniques, that allow the use of a wider range of living and hybrid materials, to produce tissues at industrial scale.

  Dr Sam Olof, Chief Technology Officer at OxSyBio, said: "There are many potential applications for bioprinting and we believe it will be possible to create personalised treatments by using cells sourced from patients to mimic or enhance natural tissue function. In the future, 3D bio-printed tissues maybe also be used for diagnostic applications - for example, for drug or toxin screening.

  "We are excited to have a continuing relationship with Oxford University and the Bayley Group, both in the form of licencing this novel technology and continuing to sponsor primary research in this area."

  Dr Adam Perriman from the University of Bristol's School of Cellular and Molecular Medicine, added: "The bioprinting approach developed with Oxford University is very exciting, as the cellular constructs can be printed efficiently at extremely high resolution with very little waste. The ability to 3D print with adult stem cells and still have them differentiate was remarkable, and really shows the potential of this new methodology to impact regenerative medicine globally."

  Explore further: Firm targets 3D printing synthetic tissues, organs 

  More information: Alexander D. Graham et al. High-Resolution Patterned Cellular Constructs by Droplet-Based 3D Printing, Scientific Reports (2017). DOI: 10.1038/s41598-017-06358-x 

  Journal reference: Scientific Reports 

版权所有 中国科学院上海硅酸盐研究所 沪ICP备05005480号
长宁园区地址:上海市长宁区定西路1295号 电话:86-21-52412990 传真:86-21-52413903 邮编:200050
嘉定园区地址:上海市嘉定区和硕路585号  电话:86-21-69906002 传真:86-21-69906700 邮编:201899